• Nenhum resultado encontrado

[PDF] Top 20 Gender influence on treatment of chronic hepatitis C genotype 1

Has 10000 "Gender influence on treatment of chronic hepatitis C genotype 1" found on our website. Below are the top 20 most common "Gender influence on treatment of chronic hepatitis C genotype 1".

Gender influence on treatment of chronic hepatitis C genotype 1

Gender influence on treatment of chronic hepatitis C genotype 1

... the treatment of chronic hepatitis C (CHC) with peginterferon (Peg-IFN) and ribavirin, litle is known regarding the real impact of gender on the characteristics ... See full document

7

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

... analysis of STAT1 in liver tissues and determined IL28B polymorphism at ...with treatment outcomes in HCV genotype 1 patients with high viral load who were receiving peginterferon plus ...(A1) ... See full document

6

INFLUENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) INFECTION ON LABORATORY PARAMETERS OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS

INFLUENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) INFECTION ON LABORATORY PARAMETERS OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS

... together, on both groups of patients hepatic function was preserved, but co-infected patients have less hepatic ...levels of ALT, with the prevalence of elevated ALT levels being lower in ... See full document

5

The Influence of Occult Infection With Hepatitis B Virus on Liver Histology and Response to Interferon Treatment in Chronic Hepatitis C Patients

The Influence of Occult Infection With Hepatitis B Virus on Liver Histology and Response to Interferon Treatment in Chronic Hepatitis C Patients

... had chronic hepatitis and 8 (14%) had liver ...(20%) of the HBV-DNA positive patients and in 6/49 (12%) of the HBV-DNA negative patients ...combination of interferon plus ribavirin (n = ... See full document

9

Major Article Influence of the inflammatory response on treatment of hepatitis C with triple therapy

Major Article Influence of the inflammatory response on treatment of hepatitis C with triple therapy

... Table 3 (G1) shows significant differences in the plasma levels of IL-6 (p=0.02) and MCP-1 (p=0.001) between the two different time points. Both treatment groups showed the upregulation of ... See full document

6

Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.

Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.

... bioavailability of interferon and ribavirin, we also noted that patients with higher BMI had higher baseline viral load, more pronounced steatosis, in addition to features of the metabolic syndrome as ... See full document

7

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil

Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil

... The treatment of chronic hepatitis C (CHC) with peginterferon alpha-2b/ribavirin (PegIFN + Rib) produced larger sustained viral response (SVR) compared to the conventional ... See full document

9

Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.

... efficacy of boceprevir and telaprevir, the most recently approved DAAs, in HCV-6 ...because of socio-economic and other obstacles ...focused on treatment of genotypes 1, 2 and 3, ... See full document

9

Major Article First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients

Major Article First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients

... to treatment were collected: viral genotype and subgenotype; history of pharmacological therapy for chronic hepatitis C; type of response to prior therapy; EHMs; degree ... See full document

9

REVIEW THE INFLUENCE OF THE HUMAN GENOME ON CHRONIC VIRAL HEPATITIS OUTCOME

REVIEW THE INFLUENCE OF THE HUMAN GENOME ON CHRONIC VIRAL HEPATITIS OUTCOME

... 30% of patients with chronic hepatitis ...HCV influence alone but also depends on collagen production by Ito cells or hepatic stellate cells ...recruitment of leukocytes and ... See full document

8

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

... for chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient ...aim of this retrospective study was ... See full document

8

Therapy of chronic hepatitis C: Virologic response monitoring

Therapy of chronic hepatitis C: Virologic response monitoring

... management of hepatitis C virus (HCV) infection in order to diagnose infection, and, most importantly, as a quide for treatment decisions and assess the virological re- sponse to antiviral ... See full document

5

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

... Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases ...era of direct- acting antivirals, these patients have become ... See full document

8

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy

... between hepatitis C virus infection, iron homeostasis and the response to antiviral treatment remains ...aim of this study was to evaluate the inluence of hepatic iron concentration ... See full document

6

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil

Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil

... the treatment of hepatitis C virus (HCV) infection is funded by the national public health system ...evaluate treatment results in the state of Mato Grosso, central Brazil, we ... See full document

7

Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns

Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns

... the treatment duration can be shortened if patients develop a rapid virological response (RVR), defined as presenting a response by week 4 of ...4 of treatment have a positive predictive value ... See full document

5

Virus C genotype predisposes to primary hypothyroidism during interferon- α treatment for chronic hepatitis C

Virus C genotype predisposes to primary hypothyroidism during interferon- α treatment for chronic hepatitis C

... Chronic hepatitis C diagnosis was investigated through alteration of qALT (ALT of patient/ALT maximum ref- erence values, RV ≤ 1), through the presence of anti- HCV ... See full document

8

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil

... no influence of Factors such as age, pre- treatment viral load, liver transplantation or HIV infection, and previous CHC treatment had no influence on ...stages of ... See full document

6

Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.

Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.

... Child-Pugh C cirrhosis, and positive hepatitis B antigen were also ...function of the patient’s weight. The initial dosage was always higher than 1 mg/kg/week subcutaneously for pegylated ... See full document

4

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.

... AF009606)) of the 38 patients, the six included genotype 1 culture viruses, and culture viruses of the other major genotypes with genotype 7a (QC69) as an out-group were aligned using ... See full document

16

Show all 10000 documents...